Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin lung function and clamp study in asthmatic versus non-asthmatic type 2 diabetes
2005-001884-80Phase 2Terminated
- Sponsor
- MannKind
- Start
- Dec 2005
- Countries
- 1
01
Overview
Phase 2, open-label trial of Technosphere insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by MannKind. Primary endpoints: Change in forced vital capacity and Change in forced expiratory volume in 1 second. Started Dec 2005; status: terminated.
02
Drugs
Technosphere insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-001884-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001884-80.